Oscar Health, Inc. (NYSE:OSCR) Given Average Rating of “Moderate Buy” by Brokerages

Oscar Health, Inc. (NYSE:OSCR) has received an average rating of “Moderate Buy” from the six research firms that are covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $13.50.

OSCR has been the subject of several research analyst reports. TheStreet upgraded shares of Oscar Health from a “d” rating to a “c-” rating in a report on Wednesday, February 21st. Wells Fargo & Company increased their price target on shares of Oscar Health from $12.00 to $20.00 and gave the stock an “overweight” rating in a research note on Thursday, February 15th. The Goldman Sachs Group increased their target price on shares of Oscar Health from $8.00 to $16.00 and gave the stock a “neutral” rating in a research note on Friday, February 9th. Finally, Raymond James assumed coverage on Oscar Health in a report on Friday, March 22nd. They issued an “outperform” rating and a $20.00 target price on the stock.

Institutional Trading of Oscar Health

A number of institutional investors have recently added to or reduced their stakes in OSCR. Envestnet Asset Management Inc. acquired a new position in shares of Oscar Health during the first quarter worth about $164,000. Advisor Group Holdings Inc. lifted its position in Oscar Health by 157.5% during the 1st quarter. Advisor Group Holdings Inc. now owns 10,106 shares of the company’s stock worth $101,000 after acquiring an additional 6,182 shares in the last quarter. Swiss National Bank boosted its holdings in Oscar Health by 8.6% in the 1st quarter. Swiss National Bank now owns 103,100 shares of the company’s stock worth $1,028,000 after acquiring an additional 8,200 shares during the period. Ergoteles LLC acquired a new stake in Oscar Health in the first quarter valued at approximately $633,000. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of Oscar Health by 2.5% during the first quarter. Charles Schwab Investment Management Inc. now owns 193,504 shares of the company’s stock valued at $1,930,000 after purchasing an additional 4,801 shares during the period. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Stock Up 5.8 %

NYSE:OSCR opened at $16.44 on Friday. Oscar Health has a 1 year low of $4.72 and a 1 year high of $18.55. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.37. The stock has a 50-day simple moving average of $15.28 and a 200-day simple moving average of $10.75.

Oscar Health (NYSE:OSCR) last posted its earnings results on Wednesday, February 7th. The company reported ($0.66) earnings per share for the quarter, topping the consensus estimate of ($0.74) by $0.08. The firm had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.43 billion. Oscar Health had a negative return on equity of 29.99% and a negative net margin of 4.62%. The firm’s revenue was up 43.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($1.05) earnings per share. On average, equities analysts forecast that Oscar Health will post -0.23 earnings per share for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.